Skip to main content
Clinical Trials/TCTR20170314001
TCTR20170314001CompletedPhase 2

Effect of probiotics for the prevention of acute radiation-induced diarrhoea among cervical cancer patients: a randomized double-blind placebo-controlled study

Self funded0 sites57 target enrollmentStarted: March 14, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
57

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 0 N/A (No limit) (—)
Sex
Female

Inclusion Criteria

  • 1. Patients with the cervical cancer (FIGO staging †I B and above) who will receive external beam radiotherapy for a minimum of 40 Gy at pelvis level with or without concurrent chemotherapy
  • 2. Age †above 18 years
  • 3. Patients with the ECOG performance status (0-2)

Exclusion Criteria

  • 1. Patients with the previous history of pelvic radiotherapy
  • 2. Patients with the history of intestinal resection
  • 3. Patients with the medical history of irritable bowel syndrome, malabsorption syndrome, inflammatory bowel disease and ileostomy
  • 4. Patients with the history of daily use of antidiarrhoeal medication before radiotherapy
  • 5. Patients with diarrhoea at the beginning of study
  • 6. Patients with immunosuppression (HIV positive, immunosuppressive drugs)
  • 7. Patients with structural heart diseases and those with prosthetic heart valves

Investigators

Sponsor
Self funded

Similar Trials